Estimands for Recurrent Event Endpoints in the Presence of a Terminal Event-Reference-Cited by-同舟云学术

Estimands for Recurrent Event Endpoints in the Presence of a Terminal Event

Published:2021-04-19 Issue: Volume: Page:1-11
ISSN:1946-6315
Container-title:Statistics in Biopharmaceutical Research
language:en
Short-container-title:Statistics in Biopharmaceutical Research

Author:

Schmidli Heinz¹,Roger James H.²,Akacha Mouna³

Affiliation:

1. Statistical Methodology, Novartis, Basel, Switzerland

2. Medical Statistics Department, London School of Hygiene & Tropical Medicine, London, UK

3. Statistical Methodology, Novartis, Basel, Switzerland, on behalf of the Recurrent Event Qualification Opinion Consortium

Publisher

Informa UK Limited

Subject

Pharmaceutical Science,Statistics and Probability

Link

https://www.tandfonline.com/doi/pdf/10.1080/19466315.2021.1895883

Reference70 articles.

1. Does Cox analysis of a randomized survival study yield a causal treatment effect?

2. Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial

3. Akacha, M., Binkowitz, B., Bretz, F., Fritsch, A., Hougaard, P., Jahn-Eimermacher, A., Mendolia, F., Ravn, H., Roger, J. H., Schlömer, P., Schmidli, H. and Wei, J. (2018), Request for CHMP Qualification Opinion: Clinically Interpretable Treatment Effect Measures based on Recurrent Event Endpoints that Allow for Efficient Statistical analyses. Recurrent Event Qualification Opinion Consortium.

4. Estimands and Their Role in Clinical Trials

5. Estimands in clinical trials - broadening the perspective

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combining Recurrent and Terminal Events Into a Composite Endpoint May Be Problematic;Statistics in Biopharmaceutical Research;2024-08-21

2. Analysis of composite time-to-event endpoints in cardiovascular outcome trials;Clinical Trials;2024-08-08

3. Marginal versus conditional rate estimation for count and recurrent event data with an estimand framework;Contemporary Clinical Trials;2024-03

4. Recurrent Events in Cardiovascular Trials;Journal of the American College of Cardiology;2023-10

5. Study Design for Restricted Mean Time Analysis of Recurrent Events and Death;Biometrics;2023-08-23